Want to track SVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sernova Biotherapeutics Inc (SVA) Statistics
Valuation metrics
Market Cap -
Enterprise value 44.83M
Trailing P/E (ttm) -3.28
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) -
Price/Book (mrq) -4.19
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.39
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 122.61K
Average volume (90 days) 118.96K
Price summary
52-Week low 0.1
52-Week high 0.2
Beta -
50-Day moving average 0.12
200-Day moving average 0.15
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:3
Last split Date 27 May 1999
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -7.71%
Return on equity 0.56%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -0.25
Current ratio (mrq) 0.14%
Book value per share (mrq) -0.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
